Skip to content
IPO

Glaxosmithkline Pharmaceuticals consolidated net profit rises 15.69% in the June 2026 quarter

N
Business Standard Markets
Aug 03, 2026 · 04:55 PM 1 min reading time
Sales rise 16.55% to Rs 938.44 crore
Read full original report at Business Standard Markets Visit Source
Related Stories
Home IPOs GMP News Toolkit